{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01375",
      "entity_text" : "TNF-alpha",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02621",
      "entity_text" : "TNF receptor",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "Cellular_component" : [ "go:GO:0016020" ],
      "Organ" : [ "uberon:UBERON:0000104" ]
    }
  },
  "verbose_text" : "Etanercept, a human recombinant TNF receptor p75 protein which binds to both TNF-alpha and TNF-beta, was one of the first biologics and has been shown to achieve a 75% or greater improvement from baseline in Patient Area and Severity Index (PASI) score (PASI75) in 34-57% of patients at week 12 [XREF_BIBR - XREF_BIBR].",
  "reading_complete" : "2020-08-04T14:26:28Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:21:47Z",
  "trigger" : "binds",
  "evidence" : [ "TNF receptor p75 protein which binds to both TNF-alpha" ],
  "pmc_id" : "6522617",
  "score" : 0
}